Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?

Brachytherapy
Shyamal PatelShalom Kalnicki

Abstract

Within a multifraction high-dose-rate vaginal cuff brachytherapy course, we determined if individual variations in organ at risk (OAR) volume and cylinder insertion geometry (CIG) impacted dose and whether planned minus fractional (P - F) differences led to a discrepancy between planned dose and delivered dose. We analyzed vaginal cuff brachytherapy applications from consecutive patients treated with three fractions of 5 Gy after each undergoing a planning CT and three repeat fractional CTs (fCTs). Rectal and bladder D2ccs and volumes were recorded in addition to the x (in relationship to midplane) and y (in relationship to the table) angles of CIG. Paired t-tests and multiple regression analyses were performed. Twenty-seven patients were identified. In comparing the planning CT vs. mean fCT rectal volumes, bladder volumes, x angles, and y angles, only bladder volume was significantly different (planned volume higher, t = 2.433, p = 0.017). The cumulative mean planned OAR D2cc vs. delivered D2cc was only significantly different for the bladder (planned dose lower, t = -2.025, p = 0.053). Regression analysis revealed planned rectal D2cc (p < 0.0003) and a positive (posterior) y insertion angle (p = 0.015) to significantly impact...Continue Reading

References

Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·J M AndersonJ Childers
Jan 30, 2002·Obstetrics and Gynecology·Neil S HorowitzTimothy P Mate
Apr 5, 2002·The British Journal of Radiology·P J HoskinA Summers
Apr 17, 2010·International Journal of Radiation Oncology, Biology, Physics·Susan RichardsonPerry W Grigsby
Jan 5, 2011·Brachytherapy·Caroline L HollowayAkila N Viswanathan
Dec 6, 2011·International Journal of Radiation Oncology, Biology, Physics·Jennifer HungRobert Y Kim
Jan 24, 2012·Brachytherapy·William SmallUNKNOWN American Brachytherapy Society
Jan 4, 2015·Gynecologic Oncology·Matthew M HarkenriderWilliam Small
Jan 7, 2015·The British Journal of Radiology·C OnalY Dolek
Apr 23, 2015·Brachytherapy·Sebastia SabaterJesus Fernandez-Lopez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.